Latest Clinical News

Melanoma Drug T-VEC Receives Recommendation for FDA Approval (05-1-2015)

An advisory panel to the U.S. Food and Drug Administration (FDA) has recommended approval of the investigational drug T-VEC (talimogene laherparepvec) for the treatment of metastatic melanoma. Biopharmaceutical company Amgen recently announced plans to... Continue Reading

Dose-Dense Chemotherapy with Ellence®, Cytoxan®, and Taxol® May Improve Survival in Node-Positive Breast Cancer (04-30-2015)

Patients with early-stage node-positive breast cancer who receive dose-dense adjuvant chemotherapy with Ellence® (epirubicin), Cytoxan® (cyclophosphamide), and Taxol® (paclitaxel) may have improved disease-free survival. These findings were released... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (04-29-2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented at the 2015 Annual Meeting on Women’s Cancer,... Continue Reading

EGFR Testing in Advanced Lung Cancer Appears Underutilized (04-28-2015)

The results of a recent survey suggest that nearly a quarter of advanced lung cancer patients fail to receive epidermal growth factor receptor (EGFR) testing before starting treatment. The recent development of drugs that target EGFR has expanded treatment... Continue Reading

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer (04-28-2015)

A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago, Illinois. According to the American Cancer Society... Continue Reading

Adcetris® after Stem Cell Transplant Improves Survival in Hodgkin’s Lymphoma (04-28-2015)

For patients with relapsed or refractory Hodgkin’s lymphoma (HL), treatment with Adcetris® (brentuximab vedotin) after autologous stem cell transplant may improve survival. The Lancet published these findings online. Hodgkin’s lymphoma is a cancer... Continue Reading

Study Demonstrates Superiority Of Kyprolis® over Velcade® in Patients With Relapsed Multiple Myeloma (04-27-2015)

The results from a planned interim analysis of the Phase 3 head-to-head clinical trial ENDEAVOR evaluating Kyprolis® (carfilzomib in combination with low-dose dexamethasone versus Velcade® (bortezomib) and low-dose dexamethasone have demonstrated that... Continue Reading

The Importance of Awareness of Breast Density and Its Impact on Cancer Screening and Risk (04-23-2015)

Women in the United States may not be adequately aware of breast density and its complications. Legislation that requires providers to discuss a woman’s breast density is likely to help build awareness. These findings were reported in the Journal of... Continue Reading

More Effective Surgery for Colon Cancer with Laparoscopic versus Open Colectomy (04-22-2015)

Less invasive surgery for colon cancer with laparoscopic colectomy improves outcomes. These findings were reported in the Journal of the National Cancer Institute. Historically, surgical treatment for colon cancer involved a procedure called open colectomy... Continue Reading

What you Need to Know about Itching and Myeloproliferative Neoplasms (04-21-2015)

What you Need to Know about Itching and Myeloproliferative Neoplasms If you have been diagnosed with myelofibrosis or polycythemia vera, you may have experienced itching as a side effect. Itching occurs as a result of the activity of cytokines (small... Continue Reading

Keytruda® May Be More Effective than Yervoy® in Advanced Melanoma (04-20-2015)

Keytruda® (pembrolizumab) appears to outperform Yervoy® (ipilimumab) at initial treatment of patients with advanced melanoma. Pharmaceutical company Merck announced these Phase III clinical trial findings in a press release in March 2015. Melanoma is... Continue Reading

Important Clues in the Development of Aggressive Thyroid Cancer (04-16-2015)

New insight into how anaplastic thyroid cancer (ATC) grows and spreads may provide important direction in the development of treatment. These findings were published in the Journal of Clinical Endocrinology and Metabolism. The thyroid is a gland in the... Continue Reading

Next Page »